Innovative Cancer Treatment: Engineered Fat Cells to "Starve" Tumors
Scientists have developed a groundbreaking treatment that uses genetically modified fat cells to slow tumor growth by depriving them of essential nutrients. In a recent study, researchers engineered white fat cells to aggressively consume nutrients like glucose and fatty acids. When these modified cells were implanted near tumors in mice, the tumors grew more slowly.
This new approach, called adipose manipulation transplantation (AMT), showed promising results even when the engineered fat cells were implanted far from the tumors. The researchers believe these cells outcompete cancer cells for nutrients, effectively suppressing tumor growth.
Unlike existing cellular therapies that use immune cells, AMT uses a patient's own fat cells, which are less likely to trigger an immune response. This makes AMT a potentially safer and more effective option for cancer treatment.
The study leader, Dr. Nadav Ahituv, suggests that this innovative therapy could be a new form of cancer treatment. Further research is needed to understand the long-term effects and potential resistance of cancer cells to this treatment. However, the findings offer hope for a nontoxic, nutrient-based approach to cancer therapy that could revolutionize treatment options in the future.
For more information click the following LINK